Mepolizumab for Eosinophilic COPD

N Engl J Med. 2018 Feb 15;378(7):680-1. doi: 10.1056/NEJMc1715454.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Asthmatic Agents*
  • Antibodies, Monoclonal, Humanized*
  • Asthma
  • Eosinophils
  • Humans
  • Pulmonary Disease, Chronic Obstructive

Substances

  • Anti-Asthmatic Agents
  • Antibodies, Monoclonal, Humanized
  • mepolizumab